Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quamrul Hassan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|September 23, 2008
Site-specific incorporation of chemical probes into proteins for NMRA Quamrul Hassan
Bioorganic & Medicinal Chemistry Letters|September 3, 2008
Mapping the subunit interface of ribonucleotide reductase (RNR) using photo cross-linkingA Quamrul Hassan, JoAnne Stubbe
Journal of the American Chemical Society|July 6, 2006
A functionally orthogonal ligand-receptor pair created by targeting the allosteric mechanism of the thyroid hormone receptorA Quamrul Hassan, John T Koh
Cell Cycle (Georgetown, Tex.)|October 9, 2010
Allosteric inhibition of BCR-ABLA Quamrul Hassan, Sreenath V Sharma, Markus Warmuth
Biochemistry|November 18, 2008
Methodology to probe subunit interactions in ribonucleotide reductasesA Quamrul Hassan, Yongting Wang, Lars Plate, et al.
Journal of Bacteriology|December 3, 2008
Functional analysis of the Streptomyces coelicolor NrdR ATP-cone domain: role in nucleotide binding, oligomerization, and DNA interactionsInna Grinberg, Tatyana Shteinberg, A Quamrul Hassan, et al.
Chemistry & Biology|December 30, 2014
The novolactone natural product disrupts the allosteric regulation of Hsp70A Quamrul Hassan, Christina A Kirby, Wenlai Zhou, et al.
Journal of Medicinal Chemistry|August 24, 2018
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini, et al.
Nature|March 23, 2017
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1Andrew A Wylie, Joseph Schoepfer, Wolfgang Jahnke, et al.
Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of <i>N</i>-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|September 23, 2008
Site-specific incorporation of chemical probes into proteins for NMRA Quamrul Hassan
Bioorganic & Medicinal Chemistry Letters|September 3, 2008
Mapping the subunit interface of ribonucleotide reductase (RNR) using photo cross-linkingA Quamrul Hassan, JoAnne Stubbe
Journal of the American Chemical Society|July 6, 2006
A functionally orthogonal ligand-receptor pair created by targeting the allosteric mechanism of the thyroid hormone receptorA Quamrul Hassan, John T Koh
Cell Cycle (Georgetown, Tex.)|October 9, 2010
Allosteric inhibition of BCR-ABLA Quamrul Hassan, Sreenath V Sharma, Markus Warmuth
Biochemistry|November 18, 2008
Methodology to probe subunit interactions in ribonucleotide reductasesA Quamrul Hassan, Yongting Wang, Lars Plate, et al.
Journal of Bacteriology|December 3, 2008
Functional analysis of the Streptomyces coelicolor NrdR ATP-cone domain: role in nucleotide binding, oligomerization, and DNA interactionsInna Grinberg, Tatyana Shteinberg, A Quamrul Hassan, et al.
Chemistry & Biology|December 30, 2014
The novolactone natural product disrupts the allosteric regulation of Hsp70A Quamrul Hassan, Christina A Kirby, Wenlai Zhou, et al.
Journal of Medicinal Chemistry|August 24, 2018
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini, et al.
Nature|March 23, 2017
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1Andrew A Wylie, Joseph Schoepfer, Wolfgang Jahnke, et al.
Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of <i>N</i>-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.
Pageof 1